Qwixel Therapeutics LLC

[Not Yet Scheduled]
Qwixel Therapeutics is an early stage Biotherapeutics company focused in Oncology. Qwixel has developed a unique and proprietary platform technology enabling the targeted delivery of Interferons to tumors while reducing their systemic activation of immune cells. An initial product designed to target multiple myeloma as well as many solid tumors has potent direct anti-tumor activity as well as the potential to stimulate an anti-tumor immune response. Qwixel has a strong IP position with an experienced management team on both the science and business ends.
Company Type:
Privately Funded Company
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2016
Main Therapeutic Focus:
Please Select
Lead Product in Development:
QXL138AM
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Speaker
photo
CSO
Qwixel Theraeputics, LLC